EU/3/09/620 - orphan designation for treatment of myelofibrosis secondary to polycythaemia vera or essential thrombocythaemia
(R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphate
Orphan
Human